The United States Trotting Association said June 16 it will fund a project designed to develop regulatory controls for the use of cobalt in racehorses.
New York is poised to become the first state to begin testing horses for blood-doping antibodies used to enhance performance, New York State Racing and Wagering Board officials have announced.
Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.
Following the lead of other states, New York racing officials have formed an advisory panel to bolster efforts to track new developments in legal and illegal drugs used in the thoroughbred industry. "There's no agenda going into this,'' said Racing and Wagering Board chairman Michael Hoblock, who announced the creation of the Medication Advisory Committee Thursday. He said the idea of such a panel came out of meetings over the past several years the racing board has held with the New York Racing Association's organization of horsemen.
Most Popular Stories
- Calumet Farm: The Rebirth of a Legend
- Shared Belief Diagnosed With Hip Fracture
- McKathans Saw Early Brilliance of 'Pharoah'
- NTRA Calls for Industry Support of Tax Reform
- What's Going On Here: America's Horse
- Shared Belief Eased as Moreno Wins CT Classic
- WinStar Farm Acquires Interest in Upstart
- Kentucky Derby Notes, April 20
- Broad Offering Should Keep OBS April Growing
- Red Cadeaux Nearing Record Earnings Plateau